OncoResponse's Series A - III Round

OncoResponse raised a round of funding on October 10, 2016.

OncoResponse mines the human adaptive immune system to discover therapeutic antibodies against novel immuno-oncology targets. By identifying candidates from the immune systems of patients who have res…

Articles about OncoResponse's Series A - III Round: